Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „week“
Suchtreffer
Begriffe & Kennungen
Cibinqo · 4.8 · Thrombocytopenia In placebo-controlled studies, for up to 16 weeks, treatment was associated with a dose-relat
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · Methotrexate Due to the presence of ASA, methotrexate used at doses higher than 20 mg/week should be used with
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · Varicella vaccine It is recommended that patients not be given salicylates for an interval of six weeks after
Eintrag öffnenColobreathe · 4.8 · In the 24 week clinical study, the following adverse reactions were observed across all ages. Frequencies are
Eintrag öffnenColobreathe · 4.8 · In the 24-week clinical study, where Colobreathe was administered twice daily to adults and children aged 6-17
Eintrag öffnenCopalia HCT · 4.8 · In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Cop
Eintrag öffnenCopalia HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenCymbalta · 4.8 · In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain,
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Daf
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenDarunavir Krka · 4.8 · In the 96 week analysis, the safety profile of darunavir/ritonavir 800/100 mg once daily in treatment- naïve s
Eintrag öffnenDarunavir Krka · 4.8 · In the 96 week analysis, the safety profile of darunavir/ritonavir 800/100 mg once daily in treatment- naïve s
Eintrag öffnenDarunavir Krka · 4.8 · Rash In clinical studies, rash was mostly mild to moderate, often occurring within the first four weeks of tre
Eintrag öffnenDarunavir Krka · 4.8 · Rash In clinical studies, rash was mostly mild to moderate, often occurring within the first four weeks of tre
Eintrag öffnenDarunavir Krka · 4.8 · The safety assessment in paediatric patients is based on the 48-week analysis of safety data from three Phase
Eintrag öffnenDarunavir Krka · 4.8 · The safety assessment of darunavir with ritonavir in paediatric patients is based on the 48-week analysis of s
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · In the 96 week analysis, the safety profile of darunavir/ ritonavir 800/100 mg once daily in treatment- naïve
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · In the 96 week analysis, the safety profile of darunavir/ritonavir 800/100 mg once daily in treatment- naïve s
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnen